Nikhil Lalwani - 08 Sep 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
08 Sep 2023
Net transactions value
-$225,833
Form type
4
Filing time
11 Sep 2023, 18:23:49 UTC
Previous filing
15 Aug 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability $225,833 -3,646 -1% $61.94 349,744 08 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 7,127 shares of restricted stock, the grant of which was previously reported.